[HTML][HTML] Parkinson disease-associated cognitive impairment
Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting>
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …
Rate of progression of mild cognitive impairment to dementia–meta‐analysis of 41 robust inception cohort studies
AJ Mitchell, M Shiri‐Feshki - Acta psychiatrica scandinavica, 2009 - Wiley Online Library
Objective: To quantify the risk of develo** dementia in those with mild cognitive
impairment (MCI). Method: Meta‐analysis of inception cohort studies. Results: Forty‐one …
impairment (MCI). Method: Meta‐analysis of inception cohort studies. Results: Forty‐one …
Revising the definition of Alzheimer's disease: a new lexicon
Alzheimer's disease (AD) is classically defined as a dual clinicopathological entity. The
recent advances in use of reliable biomarkers of AD that provide in-vivo evidence of the …
recent advances in use of reliable biomarkers of AD that provide in-vivo evidence of the …
Hierarchical feature representation and multimodal fusion with deep learning for AD/MCI diagnosis
For the last decade, it has been shown that neuroimaging can be a potential tool for the
diagnosis of Alzheimer's Disease (AD) and its prodromal stage, Mild Cognitive Impairment …
diagnosis of Alzheimer's Disease (AD) and its prodromal stage, Mild Cognitive Impairment …
Plasma phospholipids identify antecedent memory impairment in older adults
Alzheimer's disease causes a progressive dementia that currently affects over 35 million
individuals worldwide and is expected to affect 115 million by 2050 (ref. 1). There are no …
individuals worldwide and is expected to affect 115 million by 2050 (ref. 1). There are no …
Mini‐Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI)
I Arevalo‐Rodriguez, N Smailagic… - Cochrane database …, 2015 - cochranelibrary.com
Background Dementia is a progressive global cognitive impairment syndrome. In 2010,
more than 35 million people worldwide were estimated to be living with dementia. Some …
more than 35 million people worldwide were estimated to be living with dementia. Some …
Brain‐derived neurotrophic factor, depression, and physical activity: making the neuroplastic connection
C Phillips - Neural plasticity, 2017 - Wiley Online Library
Brain‐derived neurotrophic factor (BDNF) is a neurotrophin that is vital to the survival,
growth, and maintenance of neurons in key brain circuits involved in emotional and …
growth, and maintenance of neurons in key brain circuits involved in emotional and …
Early detection of Alzheimer's disease using magnetic resonance imaging: a novel approach combining convolutional neural networks and ensemble learning
Early detection is critical for effective management of Alzheimer's disease (AD) and
screening for mild cognitive impairment (MCI) is common practice. Among several deep …
screening for mild cognitive impairment (MCI) is common practice. Among several deep …
Rutin as a potent antioxidant: Implications for neurodegenerative disorders
A wide range of neurodegenerative diseases (NDs), including Alzheimer's disease,
Parkinson's disease, Huntington's disease, and prion diseases, share common mechanisms …
Parkinson's disease, Huntington's disease, and prion diseases, share common mechanisms …
Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis
Objective: Public health campaigns encouraging early help seeking have increased rates of
mild cognitive impairment (MCI) diagnosis in Western countries, but we know little about …
mild cognitive impairment (MCI) diagnosis in Western countries, but we know little about …